Answers are grounded in this paper and cite their sources.
We present a case report of hearing loss in a patient with Waldenstrom macroglobulinemia (WM) receiving treatment with bortezomib.
No takes yet. Share an insight, caveat, or question.
Fitzsimons et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: